Filter by
Filters
Filter results

Date

Primary topics

All topics

Types of content

All types

Products

All products

Diseases

All diseases

General Terms

All terms

Geography

All locations

Campaigns

All campaigns

Institutions & Events

All events and institutions
Apply
Clear all filters
55 results found
Counting of medication Co-Trimoxizole at the HIV clinic at Madi Opei health centre, Kitgum District, Uganda, November 3, 2009.
Opinion article |

What Japanese government can and should do for the affordable medicines in the world

Japan, China, South Korea, India, Australia, and New Zealand together with the 10 ASEAN countries, which comprise the Regional Comprehensive Economic Partnership (RCEP), are meeting in Kobe this week to continue trade negotiations that ...
Tags Intellectual property and trade access to medicinesgeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)
MSF treats more than 200,000 people worldwide for HIV and 97 percent of the antiretrovirals are quality, affordable generics from India. Here, an MSF doctor in Kenya consults one MSF’s thousands of HIV+ patients under treatment.
Press release |

In lead-up to RCEP trade deal negotiations in China, MSF urges countries not to trade away access to medicines

As negotiators for the Regional Comprehensive Economic Partnership (RCEP) trade agreement prepare to meet in Tianjin, China, from 17-21 October, Médecins Sans Frontières (MSF)/Doctors Without Borders urges the 16 negotiating countries ...
Tags Intellectual property and trade access to medicinesdata exclusivityintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP)UN High Level Panel on Access to Medicines
Civil society demonstration against IP provisions in RCEP that can block access to affordable medicines. Outside Ministry of Commerce, Udyog Bhawan, New Delhi
Opinion article |

The AIDS revolution is why ASEAN, India and China must resist controls on generic drugs

Dr Maria Guevara says affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia
Tags Intellectual property and trade access to medicinesgeneric medicinesintellectual property & tradeRegional Comprehensive Economic Partnership (RCEP) ASEAN